111 related articles for article (PubMed ID: 26483173)
21. Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes.
Alekseyenko AV; Kim N; Lee CJ
RNA; 2007 May; 13(5):661-70. PubMed ID: 17369312
[TBL] [Abstract][Full Text] [Related]
22. Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data.
Badr E; ElHefnawi M; Heath LS
PLoS One; 2016; 11(11):e0166978. PubMed ID: 27861625
[TBL] [Abstract][Full Text] [Related]
23. Alternative splicing regulatory network reconstruction from exon array data.
Qu K; Yesnik AM; Ortoleva PJ
J Theor Biol; 2010 Apr; 263(4):471-80. PubMed ID: 20043923
[TBL] [Abstract][Full Text] [Related]
24. Alternative Splicing in Next Generation Sequencing Data of Saccharomyces cerevisiae.
Schreiber K; Csaba G; Haslbeck M; Zimmer R
PLoS One; 2015; 10(10):e0140487. PubMed ID: 26469855
[TBL] [Abstract][Full Text] [Related]
25. Candidates for tumor-specific alternative splicing.
Okumura M; Kondo S; Ogata M; Kanemoto S; Murakami T; Yanagida K; Saito A; Imaizumi K
Biochem Biophys Res Commun; 2005 Aug; 334(1):23-9. PubMed ID: 16018876
[TBL] [Abstract][Full Text] [Related]
26. Microarray analysis of alternative splicing.
Cuperlovic-Culf M; Belacel N; Culf AS; Ouellette RJ
OMICS; 2006; 10(3):344-57. PubMed ID: 17069512
[TBL] [Abstract][Full Text] [Related]
27. Identification and expression pattern of two novel alternative splicing variants of EEF1D gene of dairy cattle.
Xie Y; Yang S; Cui X; Jiang L; Zhang S; Zhang Q; Zhang Y; Sun D
Gene; 2014 Jan; 534(2):189-96. PubMed ID: 24239553
[TBL] [Abstract][Full Text] [Related]
28. Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data.
Le K; Mitsouras K; Roy M; Wang Q; Xu Q; Nelson SF; Lee C
Nucleic Acids Res; 2004 Dec; 32(22):e180. PubMed ID: 15598820
[TBL] [Abstract][Full Text] [Related]
29. easyExon--a Java-based GUI tool for processing and visualization of Affymetrix exon array data.
Chang TY; Li YY; Jen CH; Yang TP; Lin CH; Hsu MT; Wang HW
BMC Bioinformatics; 2008 Oct; 9():432. PubMed ID: 18851762
[TBL] [Abstract][Full Text] [Related]
30. Singular Value Decomposition-based Alternative Splicing Detection.
Hu J; He X; Cote GJ; Krahe R
J Am Stat Assoc; 2009 Sep; 104(487):944-953. PubMed ID: 20305737
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing: The lord of the rings.
Ariel F; Crespi M
Nat Plants; 2017 May; 3(5):17065. PubMed ID: 28470187
[No Abstract] [Full Text] [Related]
32. [Alternative splicing and tumor].
Liu Y; Zhang HH; Xu EP
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):585-589. PubMed ID: 28810306
[No Abstract] [Full Text] [Related]
33. Alternative splicing and cancer.
Auboeuf D; Carmo-Fonseca M; Valcarcel J; Biamonti G
J Nucleic Acids; 2012; 2012():363809. PubMed ID: 22685632
[No Abstract] [Full Text] [Related]
34. Deep Learning Deepens the Analysis of Alternative Splicing.
Zou X; Gao X; Chen W
Genomics Proteomics Bioinformatics; 2019 Apr; 17(2):219-221. PubMed ID: 31100357
[No Abstract] [Full Text] [Related]
35. Alternative to Gutzwiller's approach.
Lamba S; Joshi SK
Phys Rev B Condens Matter; 1995 Sep; 52(11):7972-7975. PubMed ID: 9979794
[No Abstract] [Full Text] [Related]
36. Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.
Cesca M; Morosi L; Berndt A; Fuso Nerini I; Frapolli R; Richter P; Decio A; Dirsch O; Micotti E; Giordano S; D'Incalci M; Davoli E; Zucchetti M; Giavazzi R
Mol Cancer Ther; 2016 Jan; 15(1):125-35. PubMed ID: 26494857
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials.
Zhao L; Li W; Zhang H; Hou N; Guo L; Gao Q
Onco Targets Ther; 2015; 8():2775-81. PubMed ID: 26491352
[TBL] [Abstract][Full Text] [Related]
38. Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review.
Chen D; Zhang Y; Shi F; Li M; Zhu H; Kong L; Yu J
Onco Targets Ther; 2015; 8():2767-70. PubMed ID: 26491350
[TBL] [Abstract][Full Text] [Related]
39. Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC.
Michelsen L; Sørensen JB
Anticancer Res; 2015 Nov; 35(11):6255-9. PubMed ID: 26504059
[TBL] [Abstract][Full Text] [Related]
40. Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer.
Mahner S; Woelber L; Mueller V; Witzel I; Prieske K; Grimm D; Keller-V Amsberg G; Trillsch F
Front Oncol; 2015; 5():211. PubMed ID: 26500886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
